Using TMAs constructed from human GBM formalin-fixed paraffin-embedded tumor samples (n = 89), we used semiquantitative immunohistochemistry to analyze the level of protein expression of SOX2 and FOXO3. The gene discussed is SOX2; the disease is glioblastoma.